|
Categories:
Information |
File Type:
PDF |
Date posted:
June 2020 |
|
Categories:
Application Information |
File Type:
PDF |
Date posted:
October 2024 |
|
Categories:
Policies |
File Type:
PDF |
Date posted:
November 2024 |
|
Categories:
Policies |
File Type:
PDF |
Date posted:
November 2024 |
|
Categories:
Naloxone Opioids and Opioid Agonist Therapy |
File Type:
External Link |
|
|
Categories:
Legislation |
File Type:
External Link |
|
|
Categories:
Legislation |
File Type:
External Link |
|
|
Categories:
Information Signs and Forms |
File Type:
External Link |
|
|
Categories:
Naloxone Opioids and Opioid Agonist Therapy |
File Type:
External Link |
|
|
Categories:
Complaints |
File Type:
PDF |
Date posted:
January 2022 |
|
Categories:
Application |
File Type:
PDF |
Date posted:
January 2024 |
|
Categories:
Application |
File Type:
PDF |
Date posted:
January 2024 |
|
Categories:
Information |
File Type:
External Link |
|
|
Categories:
Opioids and Opioid Agonist Therapy |
File Type:
PDF |
Date posted:
December 2020 |
|
Categories:
COVID-19 |
File Type:
PDF |
Date posted:
April 2020 |
|
Categories:
Guidelines |
File Type:
PDF |
Date posted:
January 2018 |
|
Categories:
Information |
File Type:
PDF |
Date posted:
November 2021 |
|
Categories:
Opioids and Opioid Agonist Therapy |
File Type:
External Link |
|
|
Categories:
Legislation |
File Type:
External Link |
|
|
Categories:
Information |
File Type:
External Link |
|
|
Categories:
Signs and Forms |
File Type:
PDF |
Date posted:
November 2021 |
|
Categories:
Practice Directions and Standards of Practice |
File Type:
PDF |
Date posted:
June 2004 |
|
Categories:
Application |
File Type:
PDF |
Date posted:
June 2020 |
|
Categories:
Naloxone Opioids and Opioid Agonist Therapy |
File Type:
External Link |
|
|
Categories:
Continuing Competency |
File Type:
PDF |
Date posted:
July 2021 |
|
Categories:
Continuing Competency Signs and Forms |
File Type:
PDF |
Date posted:
January 2024 |
|
Categories:
Information |
File Type:
PDF |
Date posted:
March 2022 |
|
Categories:
Information |
File Type:
External Link |
|
|
Categories:
Application |
File Type:
PDF |
Date posted:
January 2024 |
|
Categories:
Application |
File Type:
PDF |
Date posted:
January 2024 |
|
Categories:
Information |
File Type:
PDF |
Date posted:
July 2021 |
|
Categories:
Practice Directions and Standards of Practice |
File Type:
PDF |
Date posted:
January 2011 |
|
Categories:
Guidelines Information |
File Type:
PDF |
Date posted:
January 2021 |
|
Categories:
Practice Directions and Standards of Practice |
File Type:
PDF |
Date posted:
November 2019 |
|
Categories:
Information |
File Type:
PDF |
Date posted:
May 2022 |
|
Categories:
Policies |
File Type:
PDF |
Date posted:
November 2024 |
|
Categories:
Signs and Forms |
File Type:
PDF |
Date posted:
June 2020 |
|
Categories:
Information |
File Type:
PDF |
Date posted:
May 2024 |
|
Categories:
Information |
File Type:
PDF |
Date posted:
July 2020 |
|
Categories:
Safety IQ |
File Type:
External Link |
|
|
Categories:
Information |
File Type:
External Link |
|
|
Categories:
Guidelines Manitoba Prescribing Practices Program (M3P) |
File Type:
PDF |
Date posted:
December 2019 |
|
Categories:
Practice Directions and Standards of Practice |
File Type:
PDF |
Date posted:
September 2019 |
|
Categories:
Signs and Forms |
File Type:
External Link |
|
|
Categories:
Manitoba Prescribing Practices Program (M3P) Practice Directions and Standards of Practice |
File Type:
PDF |
Date posted:
May 2024 |
|
Categories:
Application |
File Type:
PDF |
Date posted:
January 2024 |
|
Categories:
Legislation |
File Type:
External Link |
|
|
Categories:
Legislation |
File Type:
External Link |
|
|
Categories:
Information |
File Type:
External Link |
|
|
Categories:
Newsletter Opioids and Opioid Agonist Therapy |
File Type:
External Link |
|